Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Short term Debt (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Short term Debt for 11 consecutive years, with $4.7 million as the latest value for Q3 2025.

  • Quarterly Short term Debt rose 25.01% to $4.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Sep 2025, up 25.01% year-over-year, with the annual reading at $97.3 million for FY2025, N/A changed from the prior year.
  • Short term Debt hit $4.7 million in Q3 2025 for Mesa Laboratories, up from $4.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $97.3 million in Q1 2025 to a low of $235000.0 in Q1 2021.
  • Historically, Short term Debt has averaged $16.8 million across 3 years, with a median of $3.8 million in 2024.
  • Biggest five-year swings in Short term Debt: tumbled 53.37% in 2021 and later rose 25.01% in 2025.
  • Year by year, Short term Debt stood at $235000.0 in 2021, then surged by 1495.74% to $3.8 million in 2024, then grew by 25.01% to $4.7 million in 2025.
  • Business Quant data shows Short term Debt for MLAB at $4.7 million in Q3 2025, $4.2 million in Q2 2025, and $97.3 million in Q1 2025.